Vickers Venture Partners is a Singapore-rooted venture capital fund that focuses on deep-tech and hard-science startups—such as geothermal power, RNA delivery, synthetic vaccines, portable dialysis, and biodegradable plastics—that many other funds avoid due to technical complexity, betting on solving already-known global problems like disease and pollution rather than unproven markets. With a team that includes PhDs and operators from companies like HP and Apple, the fund takes an unusually hands-on role in its portfolio companies, often investing earlier than others are comfortable doing, and keeps offices in Singapore, New York, Silicon Valley, London, and Shanghai to stay close to where those companies operate.